Nuvectis Pharma NVCT
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.55 | 18 | -34.48 | -7 | -21.74 | 32 |
| 2025Q3 | 6.02 | 24 | -36.51 | -7 | -23.84 | 36 |
| 2025Q2 | 7.47 | 17 | -33.49 | -6 | -22.16 | 27 |
| 2025Q1 | 9.77 | 21 | -34.77 | -5 | -21.87 | 30 |
| 2024Q4 | 5.41 | 10 | -60.36 | -6 | -34.79 | 19 |
| 2024Q3 | 6.29 | 11 | -35.32 | -4 | -23.33 | 17 |
| 2024Q2 | 6.33 | 13 | -33.36 | -4 | -23.30 | 18 |
| 2024Q1 | 8.20 | 14 | -31.81 | -4 | -21.45 | 20 |
| 2023Q4 | 8.34 | 12 | -45.85 | -7 | -31.95 | 19 |
| 2023Q3 | 12.89 | 17 | -31.77 | -6 | -24.92 | 22 |
| 2023Q2 | 15.97 | 20 | -35.01 | -6 | -27.74 | 25 |
| 2023Q1 | 13.11 | 12 | -30.57 | -4 | -22.12 | 16 |
| 2022Q4 | 7.50 | 14 | -38.71 | -7 | -29.58 | 20 |
| 2022Q3 | 7.09 | 20 | -36.88 | -6 | -30.06 | 25 |
| 2022Q2 | 11.20 | 12 | -27.39 | -4 | -22.41 | 14 |
| 2022Q1 | 7.41 | 15 | -3 | -24.25 | 18 | |
| 2021Q4 | -11 | -2 | -33.58 | 7 | ||
| 2021Q3 | -9 | -5 | -66.58 | 7 | ||
| 2021Q2 | -4 | -6 | 7 | |||
| 2021Q1 | 0 |